Monthly Archives: November 2007

Nanotechnology set to revolutionise healthcare

November 30th, 2007|

Nanotechnology holds great promise for the development of new treatments and diagnostics. Nanotechnology may provide new drugs that are able to reach specific areas of the body more effectively and at safer doses.

Bangalore to have India’s first Nanotech Park

November 30th, 2007|

Karnataka government to set up India's first Nano Park in Bangalore and the central government will invest 250 crore.

Ikaria receives approval for INOmax®

November 29th, 2007|

Ikaria has received approval for INOmax from the Therapeutic Goods Administration, Australia.

Glenmark plans to expand in Nigeria

November 29th, 2007|

Glenmark Pharmaceuticals Nigeria, a subsidiary of Glenmark Pharmaceuticals, a global and fully integrated pharmaceutical company headquartered at Mumbai, India plans for expanding presence in the Nigerian market.

ChemGenex gets approval to demerge Verva Pharma

November 29th, 2007|

ChemGenex Pharmaceuticals Limited has received shareholder approval to demerge its metabolic diseases business, Autogen Research Limited, which is to be renamed Verva Pharmaceuticals Limited.

Cadila to launch new products soon

November 29th, 2007|

Cadila Healthcare Ltd, a flagship company of Zydus Group, will launch three-four new products under its consumer healthcare division in the next couple of years

International Roundtable on the Economics of IP – WIPO

November 28th, 2007|

The World Intellectual Property Organization (WIPO) hosted November 26 -27, 2007 a discussion grouping 15 leading economists from around the world on the economics of Intellectual Property (IP). 

GlaxoSmithKline obtains Exclusive U.S. OTC Marketing Rights to Lovastatin

November 28th, 2007|

GlaxoSmithKline (GSK) obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc. (MRK). Agreement will Broaden Access to Cholesterol-Reducing Medicine.

Dr Reddy’s signs agreement with Sygnis Pharma to supply AX200

November 28th, 2007|

Dr Reddy's Laboratories Ltd has signed an an exclusive 10-year agreement for the supply of the active ingredient AX200, a biological molecule in development.

USFDA issues warning about anti-smoking drug – Chantix

November 21st, 2007|

The U.S. Food and Drug Administration has issued an early about Pfizer Inc's anti-smoking drug, Chantix.

Nicholas Piramal announces Drug Development agreement with Merck

November 21st, 2007|

Nicholas Piramal India Limited (NPIL),and Merck & Co  has signed a  research and development collaboration agreement to discover and develop new drugs for two selected targets provided by Merck.

Frost & Sullivan 2007 Industry Best Practices Award to Masimo Corporation

November 21st, 2007|

Masimo Corporation  has receives a Frost & Sullivan 2007 Industry Best Practices Award for Pulse Oximetry Leadership. Frost & Sullivan's industry research concludes, 'Masimo pulse oximetry is the only vital sign module clinicians ask for by brand.

Sciele Pharma expands diabetes drug portfolio

November 20th, 2007|

Sciele Pharma Inc. has signed an agreement with Novo Nordisk to market exclusively Prandin, an oral blood gluclose-lowering drug.

Plethico Pharma to acquire Natrol Inc

November 20th, 2007|

Plethico Pharmaceuticals acquires US-based Natrol Inc for 80.7 million dollars  consolidating its position as a global player in herbal healthcare products.

ABPI to revise Code of Practice

November 20th, 2007|

The Association of the British Pharmaceutical Industry (ABPI)  Code of Practice is to be revised following the publication of a European-wide code on relationships between the pharmaceutical industry and patient organisations, announced the Association of the British Pharmaceutical Industry (ABPI)

Orchid receives US FDA approval for Cefpodoxime Proxetil ANDA

November 16th, 2007|

Orchid Chemicals & Pharmaceuticals Ltd has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefpodoxime Proxetil Tablets.

Wyeth receives approval from US FDA for Protonix – delayed-release Oral Suspension

November 16th, 2007|

Wyeth has received approval from US FDA for Protonix  – a new alternative for patients with erosive gastroesophageal reflux disease (GERD) who cannot swallow tablets

Proxeon and Bruker Daltonik signs OEM Agreement

November 16th, 2007|

Proxeon and Bruker Daltonik GmBH  have entered into an OEM agreement for Proxeon’s nanoscale chromatography system, EASY-nLC™ and other products for mass spectrometry.

Ranbaxy recalls gabapentin tablets in US

November 16th, 2007|

Ranbaxy Laboratories is recalling some gabapentin tablets in the United

Avandia boxed warning on label updated by USFDA

November 15th, 2007|

USFDA ask the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks